EVRG vs MAZE · P/E 22, rev $5.96B vs rev $20.0M
Evergy, Inc. (EVRG) versus Maze Therapeutics, Inc. Common Stock (MAZE) — a side-by-side from cached financials, not a winner call.
Evergy, Inc. (EVRG) is a utilities - regulated electric company listed on NASDAQ.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Latest reported EVRG revenue for 2025-12-31 was $5.96B. Net income was $855.6M. Revenue was up 2.0% from 2024-12-31 to 2025-12-31. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
Latest reported MAZE revenue for 2026-06-30 was $20.0M. Net income was -$68.9M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. MAZE currently screens at market cap $525.3M.
EVRG currently screens at market cap $19.10B and trailing P/E 22.0. MAZE currently screens at market cap $525.3M.
Not investment advice. Open the EVRG and MAZE stock pages for the full models.
Not investment advice.